Search Within

Sheng Feng Cai

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (10)
  3. Editorial (2)
  4. Review (2)
  5. Research Letter (1)
Groups
  1. Adult Leukemia (32)
  2. Center for Hematologic Malignancies (32)
  3. Department of Medicine (32)
  4. Executive Committee, Center for Hematologic Malignancies (32)
  5. GSK Faculty (32)
  6. Hematologic Malignancies, Division of (32)

More Groups

People
  1. Ross Levine (32)
  2. Wenbin Xiao (14)
  3. Christopher Famulare (13)
  4. Aaron Goldberg (12)
  5. Andrew Dunbar (12)
  6. Martin Tallman (12)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (9)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publications
  1. Blood (11)
  2. Blood Advances (4)
  3. Cancer Discovery (3)
  4. American Journal of Hematology (2)
  5. Cancer Cell (2)
  6. Nature (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Association for Cancer Research (5)
  3. Cell Press (2)
  4. John Wiley & Sons, Inc. (2)
  5. Nature Publishing Group (2)
  6. Amer Assoc Advancement Science (1)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
    Journal Article

    Xiao, W.; Miles, L. A.; Bowman, R. L.; Durani, V.; Tian, H. S.; DelGaudio, N. L.; Mishra, T.; Zhu, M.; Zhang, Y.; Stump, S. E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition
    Journal Article

    Cai, S. F.; Chu, S. H.; Goldberg, A. D.; Parvin, S.; Koche, R. P.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Genetic and epigenetic determinants of AML pathogenesis
    Review

    Cai, S. F.; Levine, R. L.
    Seminars in Hematology (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save